erlotinib hydrochloride has been researched along with Eyelid Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, JYY; Kwok, TYT; Yuen, HKL | 1 |
| Celik, T; Kosker, M | 1 |
1 review(s) available for erlotinib hydrochloride and Eyelid Diseases
| Article | Year |
|---|---|
Ocular side effects and trichomegaly of eyelashes induced by erlotinib: a case report and review of the literature.
Topics: Adenocarcinoma; Aged; Diagnosis, Differential; ErbB Receptors; Erlotinib Hydrochloride; Eyelashes; Eyelid Diseases; Female; Humans; Lung Neoplasms; Protein Kinase Inhibitors; Quinazolines | 2015 |
1 other study(ies) available for erlotinib hydrochloride and Eyelid Diseases
| Article | Year |
|---|---|
Eyelash trichomegaly induced by erlotinib for metastatic lung cancer.
Topics: Aged; Antineoplastic Agents; Erlotinib Hydrochloride; Eyelashes; Eyelid Diseases; Female; Hair Diseases; Humans; Lung Neoplasms | 2021 |